In vitro experiments showed that lowering the expression of ADAM10 by siRNA could inhibit the release of the proinflammatory cytokines TNF-α, IL-6, and IL-8 (43), improve the symptoms of arthritis, and reduce the level of vascular endothelial growth factor (VEGF) (42, 44). The gene discussed is VEGFA; the disease is arthritic joint disease.